MD Anderson and Nature to host conference on next-generation cancer therapies
A three-day 2026 conference in Houston will examine emerging cancer therapeutics, targeted protein modulation, immunotherapies and artificial intelligence in drug ...
A three-day 2026 conference in Houston will examine emerging cancer therapeutics, targeted protein modulation, immunotherapies and artificial intelligence in drug ...
Huntsman Cancer Institute will host a February 2027 multidisciplinary symposium on AI, rural access, digital health and partnerships in cancer ...
A machine learning model applied to gadoxetic acid-enhanced MRI can predict how liver metastases respond to chemotherapy and reveals that ...
A new review explains why the heat-sink effect and tumor biology undermine radiofrequency ablation for large perivascular liver cancers and ...
A multimodal deep learning model combining histopathological images with clinical data achieved 97.17 percent accuracy in stratifying colorectal cancer patients ...
A new review in the Journal of Ovarian Research argues that ovarian cancer early detection should shift from universal screening ...
A Genome Biology review charts how multi-omics technologies and artificial intelligence are transforming cancer microbiome research from observational associations toward ...
CAMBRIDGE, Mass. — Aug. 4, 2026 — A new study is showing how artificial intelligence and multi-omic biology can expose ...
The arduous journey of developing effective cancer drugs, marked by high costs and prolonged timelines, is undergoing a transformative shift ...
A groundbreaking study conducted by researchers at RCSI University of Medicine and Health Sciences in collaboration with University College Dublin ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine